CD19-selective T-cell coupling molecule for treating autoimmune diseases / autoimmune conditions

CO20260012364A2Pending Publication Date: 2026-09-28AMGEN RESEARCH (MUNICH) GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CO20260012364
Authority / Receiving Office: CO · CO
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-02-27
Filing Date: 2026-08-26
Publication Date: 2026-09-28

Application Information

Patent Timeline

27 Feb 2025

Priority

26 Aug 2026

Application

CO20260012364

28 Sep 2026

Publication

CO20260012364A2

IPC: C07K16/28; A61K39/00; A61P37/00

CPC: C07K16/2803; C07K2317/31; A61K2039/505; C07K2317/622; C07K2317/73; A61P37/00; C07K2317/76; Y02A50/30

Inventors: ZUGMAIER Gerhard

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates generally to the field of medical treatments, especially to methods for treating autoimmune diseases or autoimmune conditions with a molecule comprising a domain that binds to CD19 and a domain that binds to an immune effector cell, for example, a CD3 molecule.

Need to check novelty before this filing date? Find Prior Art